Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Universal Haplotype-Based Non Invasive Prenatal Diagnosis by Linked-Read Sequencing (10XGenomics™ Technology)

NCT03622892 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03622892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03622892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Universal Haplotype-Based Non Invasive Prenatal Diagnosis by Linked-Read Sequencing (10XGenomics™ Technology)
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
October 18, 2018
Completion date
September 5, 2022
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis